Showing results (271-280 of 537) with videos related to
Sort By:
Pageof 54
Headache|March 21, 2007
Hemicrania continua secondary to an ipsilateral brainstem lesionMarcelo M Valença, Luciana P A Andrade-Valença, Wilson Farias da Silva, et al.Headache|November 9, 2010
Antimigraine efficacy of telcagepant based on patient's historical triptan responseTony W Ho, Jes Olesen, David W Dodick, et al.Journal of Pain Research|March 4, 2021
Acute Treatment of Migraine with Celecoxib Oral Solution: Results of a Randomized, Placebo-Controlled Clinical TrialRichard B Lipton, Sagar Munjal, David W Dodick, et al.Cephalalgia : an International Journal of Headache|September 28, 2020
A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like painCaroline M Kopruszinski, Edita Navratilova, Juliana Swiokla, et al.Headache|June 21, 2007
Dihydroergotamine for early and late treatment of migraine with cutaneous allodynia: an open-label pilot trialStephen D Silberstein, William B Young, Mary M Hopkins, et al.The Journal of Headache and Pain|September 22, 2020
The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM studyStephen D Silberstein, Joshua M Cohen, Michael J Seminerio, et al.Headache|July 17, 2015
Sumatriptan Iontophoretic Transdermal System Reduces Treatment-Emergent Nausea and Is Effective in Patients With and Without Nausea at Baseline - Results From a Randomized Controlled TrialMarcelo E Bigal, Richard B Lipton, Lawrence C Newman, et al.JAMA Neurology|May 30, 2018
Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical TrialVirginia L Stauffer, David W Dodick, Qi Zhang, et al.Cephalalgia : an International Journal of Headache|August 29, 2014
Adherence to oral migraine-preventive medications among patients with chronic migraineZsolt Hepp, David W Dodick, Sepideh F Varon, et al.Cephalalgia : an International Journal of Headache|December 23, 2015
Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims databaseZsolt Hepp, Noah L Rosen, Patrick G Gillard, et al.Pageof 54